Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

MarketWatch: Yahoo’s Asian Assets Remain, But How To Extract Value Is The Issue

Therese Poletti, MarketWatch’s column writer, says that even though Carol Bartz left the company, Yahoo still has value in its Asian assets. People are willing to look past Bartz’s departure and invest or even acquire this company, just because of the support from its Asian assets.

Yahoo icon

According to Poletti, investors are focusing on Yahoo’s 40% stake of Alibaba and 35% of Yahoo Japan. Investors are hoping for an eventual IPO of Taobao under Alibaba, which would generate great profits for Yahoo. This offsets investors’ lack of confidence in Yahoo’s board and core business. Poletti said Bartz tried very hard to prevent Alibaba from buying back the stake because of the windfall from a potential IPO.

Poletti said exactly how to extract the value from Yahoo’s Asian assets is still an issue for the company. The board has been trying to find a tax efficient way to divest or sell its Yahoo Japan assets since last year.

Poletti pointed to Christopher Versace of Think 20/20, who does not think Yahoo can find a good buyer now. Versace thinks that Yahoo’s issue of not being an asset that call fill another company’s strategic hole had worsened over the past 30 months.

Poletti believes investors are keen on knowing what happens to Yahoo’s Asian assets in the near future.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!